Hend Kothayer

634 total citations
26 papers, 503 citations indexed

About

Hend Kothayer is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Hend Kothayer has authored 26 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 16 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Hend Kothayer's work include Quinazolinone synthesis and applications (9 papers), Synthesis and biological activity (8 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). Hend Kothayer is often cited by papers focused on Quinazolinone synthesis and applications (9 papers), Synthesis and biological activity (8 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). Hend Kothayer collaborates with scholars based in Egypt, United States and United Kingdom. Hend Kothayer's co-authors include Andrew D. Westwell, Samy M. Ibrahim, Mohamed M. Baraka, Samar Rezq, Damián G. Romero, Osama I. El‐Sabbagh, Malathy P.V. Shekhar, Kaushlendra Tripathi, Komaraiah Palle and Tarek S. Ibrahim and has published in prestigious journals such as Oncogene, RSC Advances and Tetrahedron Letters.

In The Last Decade

Hend Kothayer

24 papers receiving 493 citations

Peers

Hend Kothayer
Si-Tu Xue China
Andrew Germain United States
Zi Hui China
Zhitao Li China
Nikhil Reddy Madadi United States
Alan S. Florjancic United States
Si-Tu Xue China
Hend Kothayer
Citations per year, relative to Hend Kothayer Hend Kothayer (= 1×) peers Si-Tu Xue

Countries citing papers authored by Hend Kothayer

Since Specialization
Citations

This map shows the geographic impact of Hend Kothayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hend Kothayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hend Kothayer more than expected).

Fields of papers citing papers by Hend Kothayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hend Kothayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hend Kothayer. The network helps show where Hend Kothayer may publish in the future.

Co-authorship network of co-authors of Hend Kothayer

This figure shows the co-authorship network connecting the top 25 collaborators of Hend Kothayer. A scholar is included among the top collaborators of Hend Kothayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hend Kothayer. Hend Kothayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Ghareib, Salah A., et al.. (2024). Vitamin D3 mitigates myopathy and metabolic dysfunction in rats with metabolic syndrome: the potential role of dipeptidyl peptidase-4. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(4). 3697–3715. 2 indexed citations
4.
Kothayer, Hend, et al.. (2023). Triple targeting of mutant EGFR L858R/T790M , COX-2, and 15-LOX: design and synthesis of novel quinazolinone tethered phenyl urea derivatives for anti-inflammatory and anticancer evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2199166–2199166. 14 indexed citations
6.
El‐Sadek, Mohamed, et al.. (2023). Synthesis of 1,2,4‐triazole and 1,3,4‐oxadiazole derivatives as inhibitors for STAT3 enzymes of breast cancer. Archiv der Pharmazie. 356(11). e2300345–e2300345. 2 indexed citations
7.
Kothayer, Hend, et al.. (2023). Synthesis of new multitarget-directed ligands containing thienopyrimidine nucleus for inhibition of 15-lipoxygenase, cyclooxygenases, and pro-inflammatory cytokines. European Journal of Medicinal Chemistry. 256. 115443–115443. 9 indexed citations
8.
Dahal, Achyut, Sitanshu S. Singh, Samy M. Ibrahim, et al.. (2021). Quinazoline‐tethered hydrazone: A versatile scaffold toward dual anti‐TB and EGFR inhibition activities in NSCLC. Archiv der Pharmazie. 354(12). e2100281–e2100281. 10 indexed citations
9.
Rezq, Samar, et al.. (2021). Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition. European Journal of Medicinal Chemistry. 219. 113457–113457. 38 indexed citations
10.
Peigneur, Steve, Samy M. Ibrahim, Ernesto Lopes Pinheiro-Júnior, et al.. (2021). Quinazolinone dimers as a potential new class of safer Kv1 inhibitors: Overcoming hERG, sodium and calcium channel affinities. Bioorganic Chemistry. 115. 105264–105264. 1 indexed citations
12.
Kothayer, Hend, et al.. (2018). Design, synthesis and biological evaluation of novel quinazoline-2,4-diones conjugated with different amino acids as potential chitin synthase inhibitors. European Journal of Medicinal Chemistry. 152. 560–569. 17 indexed citations
14.
Kothayer, Hend, et al.. (2018). Synthesis, in vivo and in silico evaluation of novel 2,3‐dihydroquinazolin‐4(1H)‐one derivatives as potential anticonvulsant agents. Drug Development Research. 80(3). 343–352. 17 indexed citations
15.
Somasagara, Ranganatha R., Kaushlendra Tripathi, David W. Clark, et al.. (2017). RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance. Oncogene. 36(48). 6680–6690. 54 indexed citations
16.
Kothayer, Hend, et al.. (2016). Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(8). 2030–2034. 46 indexed citations
17.
Haynes, Brittany, Yanhua Zhang, Jing Li, et al.. (2015). Gold nanoparticle conjugated Rad6 inhibitor induces cell death in triple negative breast cancer cells by inducing mitochondrial dysfunction and PARP-1 hyperactivation: Synthesis and characterization. Nanomedicine Nanotechnology Biology and Medicine. 12(3). 745–757. 38 indexed citations
18.
Sanders, Matthew A., Pratima Nangia‐Makker, Vitaly Balan, et al.. (2013). Novel Inhibitors of Rad6 Ubiquitin Conjugating Enzyme: Design, Synthesis, Identification, and Functional Characterization. Molecular Cancer Therapeutics. 12(4). 373–383. 53 indexed citations
19.
Kothayer, Hend, Osama I. El‐Sabbagh, Malathy P.V. Shekhar, et al.. (2013). Design, synthesis and in vitro anticancer evaluation of 4,6-diamino-1,3,5-triazine-2-carbohydrazides and -carboxamides. Bioorganic & Medicinal Chemistry Letters. 23(24). 6886–6889. 29 indexed citations
20.
El‐Sabbagh, Osama I., Samy M. Ibrahim, Mohamed M. Baraka, & Hend Kothayer. (2010). Synthesis of New 2,3‐Dihydroquinazolin‐4(1H)‐one Derivatives for Analgesic and Anti‐inflammatory Evaluation. Archiv der Pharmazie. 343(5). 274–281. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026